Login / Signup

SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase.

Sandra HuberTorsten HaferlachManja MeggendorferStephan HutterGregor HoermannConstance BaerWolfgang KernClaudia Haferlach
Published in: Leukemia (2022)
Keyphrases
  • acute myeloid leukemia
  • allogeneic hematopoietic stem cell transplantation
  • acute lymphoblastic leukemia